200 related articles for article (PubMed ID: 36477467)
1. Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT.
Olsen KS; Jadi O; Dexheimer S; Bortone DS; Vensko SP; Bennett S; Tang H; Diiorio M; Saran T; Dingfelder D; Zhu Q; Wang Y; Haiman CA; Pooler L; Sheng X; Webb A; Pasquini MC; McCarthy PL; Spellman SR; Weimer E; Hahn T; Sucheston-Campbell L; Armistead PM; Vincent BG
Blood Adv; 2023 May; 7(9):1635-1649. PubMed ID: 36477467
[TBL] [Abstract][Full Text] [Related]
2. Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens.
Lansford JL; Dharmasiri U; Chai S; Hunsucker SA; Bortone DS; Keating JE; Schlup IM; Glish GL; Collins EJ; Alatrash G; Molldrem JJ; Armistead PM; Vincent BG
Blood Adv; 2018 Aug; 2(16):2052-2062. PubMed ID: 30115642
[TBL] [Abstract][Full Text] [Related]
3. Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data.
Armistead PM; Liang S; Li H; Lu S; Van Bergen CA; Alatrash G; St John L; Hunsucker SA; Sarantopoulos S; Falkenburg JH; Molldrem JJ
PLoS One; 2011; 6(8):e23217. PubMed ID: 21858034
[TBL] [Abstract][Full Text] [Related]
4. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
5. Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
Ofran Y; Kim HT; Brusic V; Blake L; Mandrell M; Wu CJ; Sarantopoulos S; Bellucci R; Keskin DB; Soiffer RJ; Antin JH; Ritz J
Clin Cancer Res; 2010 Mar; 16(5):1642-51. PubMed ID: 20160060
[TBL] [Abstract][Full Text] [Related]
6. Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantation.
Jadi O; Tang H; Olsen K; Vensko S; Zhu Q; Wang Y; Haiman CA; Pooler L; Sheng X; Brock G; Webb A; Pasquini MC; McCarthy PL; Spellman SR; Hahn T; Vincent B; Armistead P; Sucheston-Campbell LE
Am J Hematol; 2023 Jun; 98(6):940-950. PubMed ID: 37052167
[TBL] [Abstract][Full Text] [Related]
7. Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity.
Griffioen M; Honders MW; van der Meijden ED; van Luxemburg-Heijs SA; Lurvink EG; Kester MG; van Bergen CA; Falkenburg JH
Haematologica; 2012 Aug; 97(8):1196-204. PubMed ID: 22419570
[TBL] [Abstract][Full Text] [Related]
8. Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens.
Fuchs KJ; Honders MW; van der Meijden ED; Adriaans AE; van der Lee DI; Pont MJ; Monajemi R; Kielbasa SM; 't Hoen PAC; van Bergen CAM; Falkenburg JHF; Griffioen M
Front Immunol; 2020; 11():659. PubMed ID: 32362897
[TBL] [Abstract][Full Text] [Related]
9. Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT.
Markiewicz M; Siekiera U; Karolczyk A; Szymszal J; Helbig G; Wojnar J; Dzierzak-Mietla M; Kyrcz-Krzemien S
Bone Marrow Transplant; 2009 Feb; 43(4):293-300. PubMed ID: 18850018
[TBL] [Abstract][Full Text] [Related]
10. Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity.
Stumpf AN; van der Meijden ED; van Bergen CA; Willemze R; Falkenburg JH; Griffioen M
Blood; 2009 Oct; 114(17):3684-92. PubMed ID: 19706888
[TBL] [Abstract][Full Text] [Related]
11. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
van Balen P; Jedema I; van Loenen MM; de Boer R; van Egmond HM; Hagedoorn RS; Hoogstaten C; Veld SAJ; Hageman L; van Liempt PAG; Zwaginga JJ; Meij P; Veelken H; Falkenburg JHF; Heemskerk MHM
Front Immunol; 2020; 11():1804. PubMed ID: 32973756
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.
Warren EH; Greenberg PD; Riddell SR
Blood; 1998 Mar; 91(6):2197-207. PubMed ID: 9490709
[TBL] [Abstract][Full Text] [Related]
13. Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT.
Ritari J; Hyvärinen K; Koskela S; Niittyvuopio R; Nihtinen A; Salmenniemi U; Putkonen M; Volin L; Kwan T; Pastinen T; Itälä-Remes M; Partanen J
Front Immunol; 2019; 10():1625. PubMed ID: 31379830
[TBL] [Abstract][Full Text] [Related]
14. Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation.
Story CM; Wang T; Bhatt VR; Battiwalla M; Badawy SM; Kamoun M; Gragert L; Brown V; Baxter-Lowe LA; Marsh SGE; Gadalla SM; Schetelig J; Mytilineos J; Miklos D; Waller EK; Kuxhausen M; Spellman S; Lee S; Paczesny S; Lansford JL; Vincent BG; Riches ML; Armistead PM;
Transplant Cell Ther; 2021 Jul; 27(7):591-599. PubMed ID: 33882342
[TBL] [Abstract][Full Text] [Related]
15. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
[TBL] [Abstract][Full Text] [Related]
16. Frequencies of 10 autosomal minor histocompatibility antigens in Korean population and estimated disparities in unrelated hematopoietic stem cell transplantation.
Jung H; Ki CS; Kim JW; Kang ES
Tissue Antigens; 2012 Jan; 79(1):42-9. PubMed ID: 22150369
[TBL] [Abstract][Full Text] [Related]
17. New developments in allotransplant immunology.
Barrett AJ; Rezvani K; Solomon S; Dickinson AM; Wang XN; Stark G; Cullup H; Jarvis M; Middleton PG; Chao N
Hematology Am Soc Hematol Educ Program; 2003; ():350-71. PubMed ID: 14633790
[TBL] [Abstract][Full Text] [Related]
18. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.
Laurin D; Hannani D; Pernollet M; Moine A; Plumas J; Bensa JC; Cahn JY; Garban F
Transfusion; 2010 Feb; 50(2):418-28. PubMed ID: 19843288
[TBL] [Abstract][Full Text] [Related]
19. CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.
van Balen P; van Bergen CAM; van Luxemburg-Heijs SAP; de Klerk W; van Egmond EHM; Veld SAJ; Halkes CJM; Zwaginga JJ; Griffioen M; Jedema I; Falkenburg JHF
Front Immunol; 2018; 9():3016. PubMed ID: 30619360
[TBL] [Abstract][Full Text] [Related]
20. A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation.
Martin PJ; Levine DM; Storer BE; Zheng X; Jain D; Heavner B; Norris BM; Geraghty DE; Spellman SR; Sather CL; Wu F; Hansen JA
Front Immunol; 2021; 12():782152. PubMed ID: 34868058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
